Search Results - "Bernardo, Maria Ester"
-
1
How I treat relapsed childhood acute lymphoblastic leukemia
Published in Blood (04-10-2012)“…The most common cause of treatment failure in childhood acute lymphoblastic leukemia (ALL) remains relapse, occurring in ∼ 15%-20% of patients. Survival of…”
Get full text
Journal Article -
2
Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan
Published in Blood (12-07-2012)“…Sixty thalassemia patients (median age, 7 years; range, 1-37) underwent allogeneic hematopoietic stem cell transplantation (HSCT) after a preparation combining…”
Get full text
Journal Article -
3
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy
Published in Current pharmaceutical design (01-04-2013)“…Mesenchymal stem cells (MSCs) were first isolated more than 50 years ago from the bone marrow. Currently MSCs may also be isolated from several alternative…”
Get more information
Journal Article -
4
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Published in Cell stem cell (03-10-2013)“…In addition to their stem/progenitor properties, mesenchymal stromal cells (MSCs) possess broad immunoregulatory properties that are being investigated for…”
Get full text
Journal Article -
5
Mesenchymal Stromal Cells: Role in the BM Niche and in the Support of Hematopoietic Stem Cell Transplantation
Published in HemaSphere (01-12-2018)“…Mesenchymal stromal cells (MSCs) are key elements in the bone marrow (BM) niche where they interact with hematopoietic stem progenitor cells (HSPCs) by…”
Get full text
Journal Article -
6
An early‐senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro‐inflammatory program
Published in Aging cell (01-06-2019)“…Hematopoietic stem and progenitor cells (HSPC) reside in the bone marrow (BM) niche and serve as a reservoir for mature blood cells throughout life. Aging in…”
Get full text
Journal Article -
7
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group
Published in Haematologica (Roma) (01-10-2007)“…From Oncoematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy (FL, MZ, MEB); Clinica Pediatrica, Università di…”
Get full text
Journal Article -
8
Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders
Published in Annals of the New York Academy of Sciences (01-08-2012)“…Mesenchymal stromal cells (MSCs) are being employed in clinical trials to facilitate engraftment and to treat steroid‐resistant acute graft‐versus‐host disease…”
Get full text
Journal Article -
9
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia
Published in Nature medicine (01-02-2019)“…ß-thalassemia is caused by ß-globin gene mutations resulting in reduced (β + ) or absent (β 0 ) hemoglobin production. Patient life expectancy has recently…”
Get full text
Journal Article -
10
Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I
Published in Journal of inherited metabolic disease (01-07-2017)“…Lysosomal storage diseases (LSDs) are rare inherited metabolic disorders characterized by a dysfunction in lysosomes, leading to waste material accumulation…”
Get full text
Journal Article -
11
Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms
Published in Cancer research (Chicago, Ill.) (01-10-2007)“…Significant improvement in the understanding of mesenchymal stem cell (MSC) biology has opened the way to their clinical use. However, concerns regarding the…”
Get full text
Journal Article -
12
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art
Published in Hematology/oncology clinics of North America (01-08-2022)Get full text
Journal Article -
13
Control of immune responses by mesenchymal stromal cells
Published in Rinshō ketsueki (2014)Get more information
Journal Article -
14
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
Published in The Lancet (British edition) (10-05-2008)“…Summary Background Severe graft-versus-host disease (GVHD) is a life-threatening complication after allogeneic transplantation with haemopoietic stem cells…”
Get full text
Journal Article -
15
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
Published in Blood (26-03-2009)“…We analyzed 21 children with leukemia receiving haploidentical hematopoietic stem cell transplantation (haplo-HSCT) from killer immunoglobulin (Ig)–like…”
Get full text
Journal Article -
16
Cotransplantation of ex vivo–expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation
Published in Blood (01-10-2007)“…Haploidentical hematopoietic stem-cell transplantation (HSCT) is associated with an increased risk of graft failure. Adult bone marrow–derived mesenchymal…”
Get full text
Journal Article -
17
MPSI Manifestations and Treatment Outcome: Skeletal Focus
Published in International journal of molecular sciences (01-10-2022)“…Mucopolysaccharidosis type I (MPSI) (OMIM #252800) is an autosomal recessive disorder caused by pathogenic variants in the IDUA gene encoding for the lysosomal…”
Get full text
Journal Article -
18
Current and Future Perspective in Hematopoietic Stem Progenitor Cell‐gene Therapy for Inborn Errors of Metabolism
Published in HemaSphere (01-10-2023)Get full text
Journal Article -
19
Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches
Published in Italian journal of pediatrics (16-11-2018)“…Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a deficiency in lysosomal enzymes catalyzing the stepwise degradation of…”
Get full text
Journal Article -
20
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infection
Published in Haematologica (Roma) (01-02-2021)“…Emapalumab, a fully human anti-IFNγ monoclonal antibody, has been approved in the US as second-line treatment of primary hemophagocytic lymphohistiocytosis…”
Get full text
Journal Article